A solid start in mRNA synthesis
Ribonucleotides are the critical starting materials for the synthesis of mRNA by in vitro transcription.
Minimize risk and complications in the transition from development to industrial production of mRNA therapeutics or vaccines by relying on the same product quality from a high-volume NTP supplier:
* Consistent NTP production under GMP since 25 years.
* Obtain all natural NTPs and N1-Methyl-Pseudo-UTP from a single source.